Patents
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
04/1995
04/18/1995US5407805 Monoclonal antibody reactive to various human leukemia and lymphoma cells and methods of using same for diagnosis and treatment
04/18/1995US5407659 Treated calcium/oxyanion-containing particles for medical diagnostic imaging
04/18/1995US5407657 Hybrid magnetic resonance contrast agents
04/18/1995US5407653 Evaluation of the multidrug resistance phenotype
04/18/1995CA1335268C Methods of technetium/rhenium labeling of proteins
04/18/1995CA1335267C Method for technetium/rhenium labeling of proteins
04/15/1995CA2101623A1 A method for making 2-¬18f|fluoro-2-deoxy-d-glucose
04/13/1995WO1995009868A1 Compounds modifying serotoninergic transmission, diagnostic and therapeutic applications
04/13/1995WO1995009848A2 Polyazacycloalkanes as dichelants
04/13/1995WO1995009844A1 Rapid synthesis and use of 18f-fluoromisonidazole and analogs
04/13/1995WO1995009631A1 Spirovesamicols
04/13/1995WO1995009564A1 Compositions and methods for magnetic resonance imaging, x-ray imaging and radiopharmaceuticals
04/13/1995CA2173460A1 Compounds modifying serotoninergic transmission, diagnostic and therapeutic applications
04/13/1995CA2172735A1 Polyazacycloalkanes as dichelants
04/12/1995EP0647137A1 Glycine receptor antagonists and the use thereof
04/12/1995EP0452392B1 Heterocyclic chelating agents
04/12/1995CN1101347A Process for the manufacture of phenoxyphenoxyalkyl derivatives
04/11/1995US5405957 Wavelength-specific photosensitive compounds and expanded porphyrin-like compounds and methods of use
04/11/1995US5405597 Technetium-99m labeled somatostatin-derived peptides for imaging
04/11/1995US5405309 X-ray emitting interstitial implants
04/06/1995WO1995009013A1 Metal-binding targeted polypeptide constructs
04/06/1995WO1995003836A3 Radiolabelled glucans
04/06/1995CA2172625A1 Metal-binding targeted polypeptide constructs
04/05/1995EP0646019A1 Pretargeting methods and compounds
04/05/1995EP0469082B1 Liposomal targeting of ischemic tissue
04/04/1995US5403713 Administering detectable amount of labeled anti-elam-1 monoclonal antibody and detecting the label
04/04/1995US5403574 Evaluation and treatment of the multidrug resistance phenotype
04/04/1995US5403573 Protein composition containing amino acid residues having sulfhydryl containing side chain, beta emitting radioisotope; for treatment of arthritic joints
04/04/1995US5403572 Diagnosis/medical/
03/1995
03/30/1995WO1995008551A1 Phorbine derivatives and their use in the diagnosis and therapy of cancer
03/29/1995EP0645147A1 Determination of lymph nodes enriched in tumor reactive cells, their proliferation, and their use in adoptive cellular therapy
03/29/1995EP0645146A1 Contrast media
03/29/1995EP0644778A1 TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING.
03/29/1995EP0644775A1 Cocaine receptor binding ligands
03/29/1995EP0436005B1 Labeled polypeptide derivatives
03/28/1995US5401828 Mutant genes present in malignant tumors, detection, tumor specific antibodies for treatment
03/28/1995US5401490 Markers of tissue hypoxia
03/28/1995US5401489 Biomodulators as universal imaging agents
03/23/1995WO1995004552A3 Radiometal complexes that localise in hypoxic tissue
03/22/1995EP0643706A1 Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles
03/22/1995EP0643705A1 PROCESS FOR PRODUCING N-$g(b)-HYDROXYALKYL-TRI-N-CARBOXYALKYL-1,4,7,10-TETRAAZACYCLODODECANE AND N-$g(b)-HYDROXYALKYL-TRI-N-CARBOXYALKYL-1,4,8,11-TETRAAZACYCLOTETRADECANE DERIVATIVES AND THEIR METAL COMPLEXES
03/22/1995EP0643696A1 Azavesamicols
03/22/1995EP0643583A1 Intraoperative, intravascular and endoscopic tumor and lesion detection and therapy
03/21/1995US5399710 Protein labeling reagents
03/21/1995US5399583 Hydro-monobenzoporphyrins
03/21/1995US5399339 Process for the preparation of nitride complexes of transition metals
03/21/1995US5399338 Enhancement of abnormal tissue uptake of antibodies, tumor-specific agents or conjugates thereof for diagnostic imaging or therapy
03/16/1995WO1995007049A1 Diagnostic uses of hydrazinoadenosines
03/15/1995EP0643053A1 Process for the manufacture of phenoxyphenoxyalkyl derivatives
03/15/1995EP0642357A1 Radiolabelled peptide compounds
03/15/1995EP0414741B1 Further improvements relating to drug delivery systems
03/14/1995US5397902 Apparatus and method for the preparation of a radiopharmaceutical formulation
03/09/1995WO1995006665A1 Compositions and methods for targeting cells and modulating pulmonary surfactant secretion
03/09/1995WO1995006657A1 Interleukin-10 and immunosuppression
03/09/1995WO1995006633A1 Hydrazino-type n2s2 chelators
03/09/1995CA2169269A1 Hydrazino-type n2s2 chelators
03/08/1995EP0641796A1 Wavelength-specific cytotoxic agents
03/08/1995EP0641358A1 BINDING PEPTIDES WHICH INTERACT WITH LIGAND GROWTH FACTORS OF THE EPIDERMAL GROWTH FACTOR RECEPTOR AND erbB-2-RECEPTOR
03/08/1995EP0641222A1 TECHNETIUM-99m LABELED PEPTIDES FOR THROMBUS IMAGING
03/08/1995EP0532566B1 99m-Tc CYCLOPENTADIENYL CARBONYL COMPLEXES, METHOD OF PREPARING THEM, AND THEIR USE IN MEDICAL DIAGNOSIS
03/07/1995US5395946 Protein labels for diagnosis
03/07/1995US5395609 Synthetic peptides for use in tumor detection
03/07/1995US5395608 Triamine chelants, their derivatives, complexes and conjugates
03/02/1995WO1995006065A1 Cytokines that bind the cell surface receptor hek
03/02/1995WO1995005810A1 Compositions and methods for the detection and treatment of protein trafficking disorders and increasing secretory protein production
03/02/1995CA2169851A1 Cytokines that bind the cell surface receptor hek
03/02/1995CA2169210A1 Compositions and methods for the detection and treatment of protein trafficking disorders and increasing secretory protein production
03/01/1995EP0640211A1 Method of preparing a diagnostic agent for detecting inflammations
03/01/1995EP0640130A1 Chimeric multivalent protein analogues and methods of use thereof
03/01/1995CN1099388A Heteroatom-bearing ligands and metal complexes thereof
02/1995
02/28/1995US5393512 Comprising rhenium linked to proteinaceous targeting moiety, ascorbic acid stabilizer; purity; treating neoplastic diseases
02/24/1995CA2130503A1 Process for the manufacture of phenoxyphenoxyalkyl derivatives
02/23/1995WO1995005398A1 S3n chelating compounds for the radiolabeling of ligands, anti-ligands or other proteins
02/23/1995WO1995005394A1 Therapeutic and diagnostic agents for amyloidosis
02/23/1995CA2165538A1 S3n chelating compounds for the radiolabeling of ligands, anti-ligands or other proteins
02/22/1995EP0639083A1 Complexing agents and targeting immunoreagents
02/22/1995EP0639082A1 Method and kit for preparing technetium-99m complexes
02/22/1995EP0494176B1 Improved radionuclide generator system and method for its preparation and use
02/21/1995US5391547 Method using 5,10,15,20-tetrakis(4-carboxyphenyl)porphine for treating cancers of the lung
02/21/1995CA1334513C Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
02/16/1995WO1995004753A1 Compositions of fusion proteins containing metallothionein and targeting-protein structural components
02/16/1995WO1995004552A2 Radiometal complexes that localise in hypoxic tissue
02/16/1995WO1995004526A1 Lupane triterpenoid derivatives
02/16/1995CA2169291A1 Lupane triterpenoid derivatives
02/16/1995CA2168652A1 Radiometal complexes that localise in hypoxic tissue
02/15/1995EP0638233A1 Trap for small animals
02/15/1995EP0637968A1 TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING
02/15/1995EP0637933A1 Method and kit for imaging and treating organs and tissues
02/09/1995WO1995004114A1 Tris(isonitrile)copper(i) sulfates for preparing radionuclide complexes
02/09/1995WO1995003836A2 Radiolabelled glucans
02/09/1995WO1994027653A3 The intrapulmonary delivery of aerosolized aqueous formulations
02/08/1995EP0637336A1 Mn gene and protein
02/08/1995EP0637253A1 Carboxamide modified polyamine chelators and radioactive complexes and conjugates
02/08/1995EP0637251A1 Radiopharmaceuticals for imaging the heart
02/07/1995US5387692 Metal chelating ligands for hypoxic cells
02/07/1995US5387676 MN gene and protein
02/07/1995US5387409 Boronic acid adducts of rhenium dioxime and technetium-99m dioxime complexes containing a biochemically active group
02/07/1995US5386832 Using isotope labeled phenylalanine
02/02/1995WO1995003357A1 Biodegradable particles
02/02/1995WO1995003356A1 Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers